MACKEY CATHERINE J
Insider CIK 1645330 · SQNM Director · GWPH Director · TRIL Director · VYGR Director · PSTX Director · IDYA Director · CDMO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IDYA IDEAYA Biosciences, Inc. | A Award deriv | 2026-06-16 | 2026-06-18 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2026-06-09 | 2026-06-11 | 30,000 | — | $0 | 30,000 | SEC↗ |
| IDYA IDEAYA Biosciences, Inc. | A Award deriv | 2025-06-24 | 2025-06-26 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2025-06-03 | 2025-06-04 | 24,000 | — | $0 | 24,000 | SEC↗ |
| CDMO Avid Bioservices, Inc. | D To issuer deriv | 2025-02-05 | 2025-02-07 | 8,147 | — | $0 | 0 | SEC↗ |
| CDMO Avid Bioservices, Inc. | D To issuer deriv | 2025-02-05 | 2025-02-07 | 32,100 | — | $0 | 29,705 | SEC↗ |
| CDMO Avid Bioservices, Inc. | D To issuer deriv | 2025-02-05 | 2025-02-07 | 19,675 | — | $0 | 10,030 | SEC↗ |
| CDMO Avid Bioservices, Inc. | D To issuer deriv | 2025-02-05 | 2025-02-07 | 10,030 | — | $0 | 0 | SEC↗ |
| CDMO Avid Bioservices, Inc. | D To issuer | 2025-02-05 | 2025-02-07 | 43,379 | — | $0 | 0 | SEC↗ |
| CDMO Avid Bioservices, Inc. | M Exercise deriv | 2024-12-14 | 2024-12-17 | 26,756 | — | $0 | 0 | SEC↗ |
| CDMO Avid Bioservices, Inc. | A Award deriv | 2024-12-14 | 2024-12-17 | 8,147 | — | $0 | 8,147 | SEC↗ |
| CDMO Avid Bioservices, Inc. | M Exercise | 2024-12-14 | 2024-12-17 | 26,756 | — | $0 | 43,379 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2024-06-05 | 2024-06-07 | 24,000 | — | $0 | 24,000 | SEC↗ |
| IDYA IDEAYA Biosciences, Inc. | A Award deriv | 2024-05-31 | 2024-05-31 | 16,200 | — | $0 | 16,200 | SEC↗ |
| CDMO Avid Bioservices, Inc. | A Award deriv | 2023-12-14 | 2023-12-18 | 26,756 | — | $0 | 26,756 | SEC↗ |
| CDMO Avid Bioservices, Inc. | M Exercise deriv | 2023-12-14 | 2023-12-18 | 9,612 | — | $0 | 0 | SEC↗ |
| CDMO Avid Bioservices, Inc. | M Exercise | 2023-12-14 | 2023-12-18 | 9,612 | — | $0 | 16,623 | SEC↗ |
| IDYA IDEAYA Biosciences, Inc. | A Award deriv | 2023-06-07 | 2023-06-09 | 16,200 | — | $0 | 16,200 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2023-06-06 | 2023-06-07 | 22,000 | — | $0 | 22,000 | SEC↗ |
| CDMO Avid Bioservices, Inc. | A Award deriv | 2022-12-14 | 2022-12-16 | 9,612 | — | $0 | 9,612 | SEC↗ |
| CDMO Avid Bioservices, Inc. | M Exercise deriv | 2022-12-14 | 2022-12-16 | 4,632 | — | $0 | 0 | SEC↗ |
| CDMO Avid Bioservices, Inc. | M Exercise | 2022-12-14 | 2022-12-16 | 4,632 | — | $0 | 7,011 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2022-08-15 | 2022-08-16 | 44,000 | — | $0 | 44,000 | SEC↗ |
| IDYA IDEAYA Biosciences, Inc. | A Award deriv | 2022-04-05 | 2022-04-06 | 22,000 | — | $0 | 22,000 | SEC↗ |
| CDMO Avid Bioservices, Inc. | A Award deriv | 2021-12-14 | 2021-12-16 | 4,632 | — | $0 | 4,632 | SEC↗ |
| CDMO Avid Bioservices, Inc. | M Exercise deriv | 2021-12-14 | 2021-12-16 | 2,379 | — | $0 | 0 | SEC↗ |
| CDMO Avid Bioservices, Inc. | M Exercise | 2021-12-14 | 2021-12-16 | 2,379 | — | $0 | 2,379 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | D To issuer deriv | 2021-11-17 | 2021-11-19 | 67,000 | — | $0 | 0 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | A Award deriv | 2021-07-01 | 2021-07-02 | 67,000 | — | $0 | 67,000 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 22,464 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 34,416 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 16,548 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 35,340 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 3,144 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer | 2021-05-05 | 2021-05-07 | 10,536 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2021-03-01 | 2021-03-02 | 3,144 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2021-03-01 | 2021-03-02 | 3,144 | — | $0 | 11,796 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | F Tax w/h | 2021-03-01 | 2021-03-02 | 1,260 | $17.85 | $22.5K | 10,536 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2021-02-22 | 2021-02-24 | 22,464 | — | $0 | 22,464 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2021-01-04 | 2021-01-06 | 3,576 | — | $0 | 4 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | F Tax w/h | 2021-01-04 | 2021-01-06 | 1,440 | $9.62 | $13.9K | 8,652 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2021-01-04 | 2021-01-06 | 3,576 | — | $0 | 10,092 | SEC↗ |
| CDMO Avid Bioservices, Inc. | A Award deriv | 2020-12-14 | 2020-12-16 | 2,379 | — | $0 | 2,379 | SEC↗ |
| CDMO Avid Bioservices, Inc. | A Award deriv | 2020-12-14 | 2020-12-16 | 10,030 | — | $0 | 61,805 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2020-07-09 | 2020-07-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2020-06-04 | 2020-06-08 | 34,416 | — | $0 | 34,416 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2020-03-02 | 2020-03-04 | 1,356 | $8.35 | $11.3K | 16,392 | SEC↗ |
| CDMO Avid Bioservices, Inc. | A Award deriv | 2020-01-09 | 2020-01-13 | 19,675 | — | $0 | 51,775 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2020-01-03 | 2020-01-07 | 1,536 | $8.54 | $13.1K | 17,748 | SEC↗ |
| CDMO Avid Bioservices, Inc. | A Award deriv | 2019-07-25 | 2019-07-26 | 32,100 | — | $0 | 32,100 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2019-03-13 | 2019-03-15 | 888 | $14.39 | $12.8K | 19,284 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2019-03-01 | 2019-03-05 | 3,144 | — | $0 | 3,144 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2019-03-01 | 2019-03-05 | 3,144 | — | $0 | 3,144 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2019-03-01 | 2019-03-05 | 16,548 | — | $0 | 16,548 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2019-03-01 | 2019-03-05 | 3,144 | — | $0 | 3,144 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2019-01-03 | 2019-03-15 | 3,580 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2019-01-03 | 2019-03-15 | 3,580 | — | $0 | 20,172 | SEC↗ |
| SQNM SEQUENOM INC | D To issuer deriv | 2016-09-07 | 2016-09-07 | 8,571 | — | $0 | 0 | SEC↗ |
| SQNM SEQUENOM INC | D To issuer deriv | 2016-09-07 | 2016-09-07 | 20,000 | — | $0 | 0 | SEC↗ |
| SQNM SEQUENOM INC | U Tender | 2016-09-07 | 2016-09-07 | 21,114 | — | $0 | 0 | SEC↗ |
| SQNM SEQUENOM INC | A Award deriv | 2016-06-15 | 2016-06-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SQNM SEQUENOM INC | A Award deriv | 2016-01-04 | 2016-01-06 | 8,571 | — | $0 | 8,571 | SEC↗ |
| SQNM SEQUENOM INC | A Award | 2016-01-04 | 2016-01-06 | 21,114 | — | $0 | 21,114 | SEC↗ |
| SQNM SEQUENOM INC | A Award deriv | 2015-06-17 | 2015-06-18 | 20,000 | — | $0 | 20,000 | SEC↗ |